The Drug Tariff Unpacked, Explained and Demystified
Tuesday 8th September 2026 13:00 - 14:00 (BST)
Decode primary care reimbursement and strengthen your NHS commercial strategy
Masterclass Details:
The Drug Tariff, in combination with the Dictionary of Medicines and Devices (dm+d), determines the reimbursement price of most medicines and devices dispensed in primary care. It’s vital that these factors are understood and incorporated when you’re planning your commercial strategic approach towards the NHS. But are you sufficiently aware of them?
If not, or you need a deeper understanding, then this essential 60-minute masterclass with market access expert Greg Bull is for you. Greg will help you understand how Drug Tariff and dm+d changes can directly impact primary care prescribing, reimbursement and commercial strategy across England.
Primary care dispensing is worth billions of pounds annually in England alone, but pharma and medtech companies sometimes spend a lot of time and effort selling or pitching to the NHS without enough understanding of the commercial proposition and the factors that influence the cost of medicines. Knowledge of Drug Tariff and dm+d considerations is vital for companies that want to achieve commercial success without wasting resources.
Join live to ask your questions, demystify the Drug Tariff and avoid being caught out!
Key Learning Objectives:
- Explore the relationship between Drug Tariff and dm+d
- Understand the most important sections and chapters of the Drug Tariff
- Understand how Category A, Category C and Category M Drug Tariff prices are calculated and the importance of primary care reimbursement prices
- Understand the new Category H changes and the potential impact on primary care reimbursement prices
LSAA reserves the right to restrict access to this webinar to LSAA members
-
Date and time
8th Sep 2026 13:00 – 14:00 (BST)
